-+ 0.00%
-+ 0.00%
-+ 0.00%

PFIZER- PLAN TO ADVANCE PHASE 3 PROGRAM FOR BEROBENATIDE THAT INCLUDES 10 STUDIES FOR CHRONIC WEIGHT MANAGEMENT, OBESITY-RELATED CONDITIONS THIS YEAR

路透·08/04/2026 10:48:05

登录查看新闻详情